Home Infusion Therapy Market Size, Share, Growth Analysis, By Indication Analysis(Enteral Nutrition, Anti-Infective, Chemotherapy, Parenteral Nutrition), By Product Analysis(Devices, Drugs, Services), By Region - Industry Forecast 2024-2031

The competitive landscape of the global home infusion therapy market outlook is characterized by the presence of numerous established players and emerging companies focusing on innovative solutions. Some of the major foreign players are Baxter International, B. Braun Melsungen AG, Smiths Medical, and Fresenius Kabi. These companies are continually working to create new infusion devices which enhance the safety and comfort of patients, while also widening their range of products. Strategic alliances and technological developments are among the key drivers of competition and market growth in this dynamic sector.

Top Players in Global Home Infusion Therapy Market

• B. Braun Melsungen AG
• Baxter International Inc.
• Fresenius Kabi AG
• ICU Medical, Inc.
• Smiths Medical, Inc.
• CareFusion Corporation
• Terumo Corporation
• Caesarea Medical Electronics Ltd.
• JMS Co., Ltd.
• Eli Lilly and Company
• Pfizer Inc.
• Novartis AG
• Johnson & Johnson
• Becton, Dickinson and Company
• Roche Holding AG
• Cigna Corporation
• Optum, Inc.
• Medtronic Plc
• 3M Company
• Omnicell, Inc.

Home Infusion Therapy Market Recent Development

• In October 2023, Baxter International announced the release of its latest infusion therapy management system targeted at improving patient safety in home infusion therapies. This sophisticated platform incorporates novel features such as analytics and live streaming, which enables effective use of medication to enhance the end results for patients and still follow the regulations. 
• In September 2023, Medtronic introduced the new insulin pumping technology designed especially for home infusion therapy applied to the treatment and management of diabetes. The device incorporates intelligent technologies that make insulin adjustments more patient specific making it easier for patients to manage their condition. This advancement seeks to enhance patient compliance and minimize hospital visits. 
• In August 2023, To address the issues in the home health care segment, ICU Medical, Inc. has launched a portable infusion pump. The pumps are simple to operate and come with easy-to-read displays as well as additional safety features. The intention of the launch is to seek and enable treatment in the comfort of one’s home for patients requiring chronic treatment.